These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7381692)

  • 1. Clearance calculations in hemodialysis: application to blood, plasma, and dialysate measurements for ethambutol.
    Lee CS; Marbury TC; Benet LZ
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):69-81. PubMed ID: 7381692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance and recovery calculations in hemodialysis: application to plasma, red blood cells, and dialysate measurements for cyclophosphamide.
    Wang LH; Lee CS; Majeske BL; Marbury TC
    Clin Pharmacol Ther; 1981 Mar; 29(3):365-72. PubMed ID: 7471607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis of acetaminophen in uremic patients.
    Marbury TC; Wang LH; Lee CS
    Int J Artif Organs; 1980 Sep; 3(5):263-6. PubMed ID: 7461859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of dyphylline elimination by uremic patients.
    Lee CC; Wang LH; Majeske BL; Marbury TC
    J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis.
    Lee CS; Wang LH; Marbury TC; Bruni J; Perchalski RJ
    Clin Toxicol; 1980 Oct; 17(3):429-38. PubMed ID: 7449356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis.
    Lindsay RM; Bene B; Goux N; Heidenheim AP; Landgren C; Sternby J
    Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
    Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of primidone elimination by uremic patients.
    Lee CS; Marbury TC; Perchalski RT; Wilder BJ
    J Clin Pharmacol; 1982 Jul; 22(7):301-8. PubMed ID: 7107978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radionuclide method for evaluating the performance of hemodialysis in vivo.
    Bihl GR; Bird NJ; Peters C; Bradley JR; Peters AM
    Kidney Int; 2005 Feb; 67(2):721-31. PubMed ID: 15673322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hemodialyzer reuse: dissociation between clearances of small and large solutes.
    Leypoldt JK; Cheung AK; Deeter RB
    Am J Kidney Dis; 1998 Aug; 32(2):295-301. PubMed ID: 9708616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodialysis clearance of chloroquine in uremic patients.
    Akintonwa A; Odutola TA; Edeki T; Mabadeje AF
    Ther Drug Monit; 1986; 8(3):285-7. PubMed ID: 3750371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceforanide pharmacokinetics in haemodialysis: the effect of ultrafiltration.
    Lanao JM; de Prada CR; Dominguez-Gil A; Tabernero JM; Martín J; Gómez JR
    Biopharm Drug Dispos; 1986; 7(4):335-46. PubMed ID: 3768489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing residual renal function and efficiency of hemodialysis--an application for urographic contrast media.
    Sterner G; Frennby B; Månsson S; Ohlsson A; Prütz KG; Almén T
    Nephron; 2000 Aug; 85(4):324-33. PubMed ID: 10940743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of gentamicin during hemodialysis: comparison of four artificial kidneys.
    Halpren BA; Axline SG; Coplon NS; Brown DM
    J Infect Dis; 1976 Jun; 133(6):627-36. PubMed ID: 932490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis Clearance of Enarodustat (JTZ-951), an Oral Erythropoiesis Stimulating Agent, in Patients with End-Stage Renal Disease.
    Pai SM; Yamada H
    Clin Pharmacol Drug Dev; 2021 May; 10(5):463-470. PubMed ID: 33788422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
    Jitmuang A; Nation RL; Koomanachai P; Chen G; Lee HJ; Wasuwattakul S; Sritippayawan S; Li J; Thamlikitkul V; Landersdorfer CB
    J Antimicrob Chemother; 2015; 70(6):1804-11. PubMed ID: 25698772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
    Azar AT
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique.
    Ronco C; Brendolan A; Crepaldi C; Rodighiero M; Scabardi M
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S53-61. PubMed ID: 11792763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis of theophylline in uremic patients.
    Lee CS; Marbury TC; Perrin JH; Fuller TJ
    J Clin Pharmacol; 1979 Apr; 19(4):219-26. PubMed ID: 438357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new method of post-dialysis blood urea sampling: the 'stop dialysate flow' method.
    Geddes CC; Traynor J; Walbaum D; Fox JG; Mactier RA
    Nephrol Dial Transplant; 2000 Apr; 15(4):517-23. PubMed ID: 10727547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.